StockDriftsStockDriftsTop 2 Skorpios Trust Holdings
| Stock | Company | % Port. | Shares | Value | Activity | Ownership | Avg. Cost | Date |
|---|---|---|---|---|---|---|---|---|
| STOK | STOKE THERAPEUTICS INC | 99.68% | 2.26M | $53.0M | -30.71%(-1.00M) | $23.70(+34.68%) | 2025-09-30 | |
| XBI | SPDR SER TR | 0.32% | 1.7K | $169K | +0.00%(+0) | $118.76(+5.23%) | 2025-09-30 |
| Performance Metric | 3-Year Annualized | 3-Year Cumulative | 5-Year Annualized | 5-Year Cumulative | Since First Filing (12 quarters) |
|---|---|---|---|---|---|
| Top 20 Holdings Weighted | +59.32% | +304.42% | — | — | +304.42% |
| Top 20 Holdings Unweighted | +49.25% | +232.45% | — | — | +232.45% |
Skorpios Trust reports $53.19M in US-listed equity holdings across 2 positions in its most recent 13F filing. Its largest disclosed positions are STOK (99.7%) and XBI (0.3%). The top 20 holdings account for 100% of reported assets. Its disclosed equity book has returned +304.42% on a three-year cumulative basis. Figures reflect the Q3 2025 filing.
Portfolio changes
Every reported change this quarter, grouped by direction. The signal is in the rotation, not any single trade.
Sign up free to track Skorpios Trust, compare funds side by side, and get alerts the moment positions change.
Holdings on this page are parsed from Skorpios Trust’s Form 13F filings with the U.S. Securities and Exchange Commission (CIK 1869333). View Skorpios Trust’s 13F filings on SEC